BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg. 1998;176:335-338. [PMID: 9817250 DOI: 10.1016/s0002-9610(98)00204-9] [Cited by in Crossref: 158] [Cited by in F6Publishing: 67] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22:881-886. [PMID: 17245566 DOI: 10.1007/s00384-006-0259-6] [Cited by in Crossref: 296] [Cited by in F6Publishing: 289] [Article Influence: 19.7] [Reference Citation Analysis]
2 Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, Kusunoki M. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci. 2004;49:970-976. [PMID: 15309885 DOI: 10.1023/B: DDAS.0000034556.48527.6e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 McMillan DC, Canna K, McArdle CS. The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer. Br J Cancer 2003;89:612-4. [PMID: 12915865 DOI: 10.1038/sj.bjc.6601156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kinoshita A, Onoda H, Takano K, Imai N, Saeki C, Fushiya N, Miyakawa Y, Nishino H, Tajiri H. Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma. Med Oncol. 2012;29:2800-2808. [PMID: 22460836 DOI: 10.1007/s12032-012-0220-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
5 Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Tominaga M, Okunaga R, Shibata K, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection. J Gastrointest Surg. 2007;11:596-602. [PMID: 17468918 DOI: 10.1007/s11605-007-0140-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
6 Roxburgh CS, Wallace AM, Guthrie GK, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Dis. 2010;12:987-994. [PMID: 25216413 DOI: 10.9738/intsurg-d-13-00118.1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
7 Chen W, Wang JB, Abnet CC, Dawsey SM, Fan JH, Yin LY, Yin J, Taylor PR, Qiao YL, Freedman ND. Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2015;24:386-92. [PMID: 25613115 DOI: 10.1158/1055-9965.EPI-14-1038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Jun CH, Ki HS, Lee KH, Park KJ, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK. Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE. Clin Mol Hepatol. 2013;19:70-77. [PMID: 23593612 DOI: 10.3350/cmh.2013.19.1.70] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
9 Zhao J, Xu J, Zhang R. Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery. Med Sci Monit 2017;23:4826-33. [PMID: 28988257 DOI: 10.12659/msm.904116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zahlten-Hinguranage A, Goldschmidt H, Cremer FW, Egerer G, Moehler T, Witte D, Bernd L, Sabo D, Zeifang F. Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgery. Br J Cancer 2006;95:782-7. [PMID: 16969356 DOI: 10.1038/sj.bjc.6603329] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
11 Ivancic MM, Megna BW, Sverchkov Y, Craven M, Reichelderfer M, Pickhardt PJ, Sussman MR, Kennedy GD. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers. J Surg Res. 2020;246:160-169. [PMID: 31586890 DOI: 10.1016/j.jss.2019.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Richardson JJR, Hendrickse C, Gao-Smith F, Thickett DR. Neutrophil extracellular trap production in patients with colorectal cancer in vitro. Int J Inflam. 2017;2017:4915062. [PMID: 28828191 DOI: 10.1155/2017/4915062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
13 Sokolov M, Angelov K, Vasileva M, Atanasova MP, Vlahova A, Todorov G. Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer. Onco Targets Ther 2015;8:2329-37. [PMID: 26366089 DOI: 10.2147/OTT.S82958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Walsh SR, Gladwish KM, Ward NJ, Justin TA, Keeling NJ. Atrial fibrillation and survival in colorectal cancer. World J Surg Oncol 2004;2:40. [PMID: 15569387 DOI: 10.1186/1477-7819-2-40] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
15 Maeda K, Shibutani M, Otani H, Nagahara H, Ikeya T, Iseki Y, Tanaka H, Muguruma K, Hirakawa K. Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastrointest Oncol 2015; 7(8): 111-117 [PMID: 26306143 DOI: 10.4251/wjgo.v7.i8.111] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
16 Yamashita H, Kitayama J, Taguri M, Nagawa H. Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg. 2009;33:1298-1305. [PMID: 19347392 DOI: 10.1007/s00268-009-9992-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
17 Cho DS, Kim SJ, Lee SH, Ahn HS, Kim YS, Kim SI. Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma. Korean J Urol 2011;52:104-9. [PMID: 21379426 DOI: 10.4111/kju.2011.52.2.104] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
18 Canna K, McMillan DC, McKee RF, McNicol AM, Horgan PG, McArdle CS. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer. 2004;90:1707-1709. [PMID: 15150596 DOI: 10.1038/sj.bjc.6601757] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
19 Xynos ID, Kavantzas N, Tsaousi S, Zacharakis M, Agrogiannis G, Kosmas C, Lazaris A, Sarantonis J, Sougioultzis S, Tzivras D, Polyzos A, Patsouris ES, Tsavaris N. Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy. ISRN Gastroenterol 2013;2013:490578. [PMID: 23840958 DOI: 10.1155/2013/490578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
20 Gerhardt T, Milz S, Schepke M, Feldmann G, Wolff M, Sauerbruch T, Dumoulin FL. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol 2006; 12(34): 5495-5500 [PMID: 17006987 DOI: 10.3748/wjg.v12.i34.5495] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
21 Anderson L, Razavi M, Pope ME, Yip R, Cameron LC, Bassini-Cameron A, Pearson TW. Precision multiparameter tracking of inflammation on timescales of hours to years using serial dried blood spots. Bioanalysis 2020;12:937-55. [PMID: 32253915 DOI: 10.4155/bio-2019-0278] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bolayirli M, Turna H, Orhanoğlu T, Ozaras R, Ilhan M, Ozgüroğlu M. C-reactive protein as an acute phase protein in cancer patients. Med Oncol 2007;24:338-44. [PMID: 17873311 DOI: 10.1007/s12032-007-0012-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
23 Toiyama Y, Fujikawa H, Koike Y, Saigusa S, Inoue Y, Tanaka K, Mohri Y, Miki C, Kusunoki M. Evaluation of preoperative C-reactive protein aids in predicting poor survival in patients with curative colorectal cancer with poor lymph node assessment. Oncol Lett 2013;5:1881-8. [PMID: 23833661 DOI: 10.3892/ol.2013.1308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
24 Bosscher MR, Bastiaannet E, van Leeuwen BL, Hoekstra HJ. Factors Associated with Short-Term Mortality After Surgical Oncologic Emergencies. Ann Surg Oncol 2016;23:1803-14. [PMID: 26553441 DOI: 10.1245/s10434-015-4939-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
25 Nozoe T, Iguchi T, Adachi E, Matsukuma A, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today 2011;41:510-3. [PMID: 21431483 DOI: 10.1007/s00595-009-4297-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
26 Deichmann M, Kahle B, Moser K, Wacker J, Wüst K. Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase. Br J Cancer 2004;91:699-702. [PMID: 15280926 DOI: 10.1038/sj.bjc.6602043] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
27 Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, McMillan DC. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 2007;97:1266-70. [PMID: 17923866 DOI: 10.1038/sj.bjc.6604027] [Cited by in Crossref: 206] [Cited by in F6Publishing: 202] [Article Influence: 13.7] [Reference Citation Analysis]
28 Park DS, Kim D, Hwang KE, Hwang YR, Park C, Seol CH, Cho KH, Kim BR, Park SH, Jeong ET, Kim HR. Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions. Yonsei Med J 2013;54:396-402. [PMID: 23364973 DOI: 10.3349/ymj.2013.54.2.396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Takamizawa Y, Shida D, Boku N, Nakamura Y, Ahiko Y, Yoshida T, Tanabe T, Takashima A, Kanemitsu Y. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer. BMC Cancer 2020;20:1092. [PMID: 33176752 DOI: 10.1186/s12885-020-07560-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Huang Y, Feng JF, Liu JS, Chen QX. Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis. Ther Clin Risk Manag 2015;11:89-94. [PMID: 25653533 DOI: 10.2147/TCRM.S70954] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
31 Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, Kusunoki M. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci. 2004;49:970-976. [PMID: 15309885 DOI: 10.1023/b:ddas.0000034556.48527.6e] [Cited by in Crossref: 79] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
32 Imai N, Kinoshita A, Onoda H, Iwaku A, Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H, Tajiri H. Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma. Clin Transl Oncol 2013;15:575-81. [PMID: 23263911 DOI: 10.1007/s12094-012-0976-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
33 Nakagawa K, Tanaka K, Nojiri K, Kumamoto T, Takeda K, Ueda M, Endo I. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2014;21:1711-1718. [PMID: 24452408 DOI: 10.1245/s10434-013-3342-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
34 Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K. Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer. Surg Today. 2015;45:315-321. [PMID: 24817059 DOI: 10.1007/s00595-014-0909-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
35 Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G, Kostakis A, Peros G. Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients: Prognostic implications. World J Gastroenterol 2005; 11(11): 1639-1643 [PMID: 15786541 DOI: 10.3748/wjg.v11.i11.1639] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
36 Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One 2015;10:e0143080. [PMID: 26717416 DOI: 10.1371/journal.pone.0143080] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 16.1] [Reference Citation Analysis]
37 Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2011;2:95-101. [PMID: 22977476 DOI: 10.3892/etm.2010.175] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
38 Hong J, Woo HS, Ahn HK, Sym SJ, Park J, Cho EK, Shin DB, Lee JH. Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia. Support Care Cancer 2016;24:187-94. [PMID: 25980681 DOI: 10.1007/s00520-015-2762-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
39 Prins RC, Rademacher BL, Mongoue-Tchokote S, Alumkal JJ, Graff JN, Eilers KM, Beer TM. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. Urol Oncol 2012;30:33-7. [PMID: 20207556 DOI: 10.1016/j.urolonc.2009.11.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
40 Ito T, Shinkawa H, Takemura S, Tanaka S, Nishioka T, Miyazaki T, Ishihara A, Kubo S. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma. Asian Pac J Cancer Prev 2020;21:2373-9. [PMID: 32856868 DOI: 10.31557/APJCP.2020.21.8.2373] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Ma LN, Liu XY, Lu ZH, Wu LG, Tang YY, Luo X, Hu YC, Yan TT, Wang Q, Ding XC, Xie Y. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis. Oncol Lett 2017;13:3457-64. [PMID: 28521452 DOI: 10.3892/ol.2017.5890] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
42 Harimoto N, Shirabe K, Abe T, Kajiyama K, Nagaie T, Gion T, Kuroda Y, Maehara Y. Interleukin-8 producing hepatocellular carcinoma with pyrexia. HPB Surg 2009;2009:461492. [PMID: 19707535 DOI: 10.1155/2009/461492] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
43 Passardi A, Scarpi E, Cavanna L, Dall'Agata M, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Brandes AA, Tenti E, Vespignani R, Frassineti GL, Amadori D, De Giorgi U. Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. Oncotarget 2016;7:33210-9. [PMID: 27120807 DOI: 10.18632/oncotarget.8901] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 15.4] [Reference Citation Analysis]
44 Xu Y, Li Z, Shen-Tu Y. [The prognostic value of detection of serum C-reactive protein in the patients with stage I lung cancer]. Zhongguo Fei Ai Za Zhi 2011;14:400-3. [PMID: 21569644 DOI: 10.3779/j.issn.1009-3419.2011.05.04] [Reference Citation Analysis]
45 Mori K, Toiyama Y, Saigusa S, Fujikawa H, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Tanaka K. Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery. Dig Dis Sci. 2015;60:2477-2487. [PMID: 25840921 DOI: 10.1007/s10620-015-3648-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
46 Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR, Le Marchand L, Chan AT, Goode EL, Ulrich CM, Hung RJ. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev 2014;23:1729-51. [PMID: 24962838 DOI: 10.1158/1055-9965.EPI-14-0064] [Cited by in Crossref: 71] [Cited by in F6Publishing: 33] [Article Influence: 8.9] [Reference Citation Analysis]
47 Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer. 2010;10:203. [PMID: 20465852 DOI: 10.1186/1471-2407-10-203] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
48 da Silveira da Rocha TM, Miranda Silva AL, Fortier SC, Chiattone CS. Evaluation correlates C-reactive protein with advanced stage Hodgkin's lymphoma and response to treatment in a tertiary university hospital in Brazil. Rev Bras Hematol Hemoter 2015;37:242-6. [PMID: 26190427 DOI: 10.1016/j.bjhh.2015.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Wu J, Cai Q, Li H, Cai H, Gao J, Yang G, Zheng W, Xiang YB, Shu XO. Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis 2013;34:2799-803. [PMID: 23985781 DOI: 10.1093/carcin/bgt288] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
50 Gockel I, Dirksen K, Messow CM, Junginger T. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 2006; 12(23): 3746-3750 [PMID: 16773693 DOI: 10.3748/wjg.v12.i23.3746] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 70] [Article Influence: 4.5] [Reference Citation Analysis]
51 Jeon HJ, Kim JM, Cho CK, Lee YW, Yoo HS. Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV Cancer. J Pharmacopuncture 2015;18:19-31. [PMID: 26388999 DOI: 10.3831/KPI.2015.18.021] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Kim JM, Kwon CH, Joh JW, Ko JS, Park JB, Lee JH, Kim SJ, Paik SW, Park CK. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol. 2013;11:92. [PMID: 23618082 DOI: 10.1186/1477-7819-11-92] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
53 Zheng Z, Zhou L, Gao S, Yang Z, Yao J, Zheng S. Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci. 2013;10:653-664. [PMID: 23569429 DOI: 10.7150/ijms.6050] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
54 Hua X, Kratz M, Malen RC, Dai JY, Lindström S, Zheng Y, Newcomb PA. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients. Br J Cancer 2021. [PMID: 34230610 DOI: 10.1038/s41416-021-01458-y] [Reference Citation Analysis]
55 Nozoe T, Mori E, Takahashi I, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today. 2008;38:597-602. [PMID: 18612783 DOI: 10.1007/s00595-007-3680-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
56 Hong S, Kang YA, Cho BC, Kim DJ. Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J. 2012;53:111-117. [PMID: 22187240 DOI: 10.3349/ymj.2012.53.1.111] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
57 Contu PC, Contu SS, Rosito MA, Moreira LF. Expression of C-Reactive Protein in Rectal Cancer. Gastroenterology Res 2009;2:104-9. [PMID: 27956962 DOI: 10.4021/gr2009.03.1279] [Reference Citation Analysis]
58 Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell'Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P. Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier). Cancer Manag Res 2019;11:3631-42. [PMID: 31118786 DOI: 10.2147/CMAR.S197349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Noguchi D, Kuriyama N, Nakagawa Y, Maeda K, Shinkai T, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Kishiwada M, Sakurai H, Mizuno S. The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers. PLoS One 2021;16:e0245946. [PMID: 33507925 DOI: 10.1371/journal.pone.0245946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Sato M, Takeyama H. Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients. Gastroenterol Res Pract 2016;2016:9701574. [PMID: 26858756 DOI: 10.1155/2016/9701574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
61 Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer 2011;104:51-9. [PMID: 21081932 DOI: 10.1038/sj.bjc.6606005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
62 Hayashi T, Shibata M, Oe S, Miyagawa K, Honma Y, Harada M. C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib. PLoS One 2020;15:e0244370. [PMID: 33351844 DOI: 10.1371/journal.pone.0244370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Dajani K, O'Reilly DA, Carino NL, Ghaneh P, Poston G, Wu A. The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg 2009;2009:425065. [PMID: 19750237 DOI: 10.1155/2009/425065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
64 Ito A, Ishida T. Diagnostic markers for community-acquired pneumonia. Ann Transl Med 2020;8:609. [PMID: 32566635 DOI: 10.21037/atm.2020.02.182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
65 Wang H, Wang MS, Zhou YH, Shi JP, Wang WJ. Prognostic Values of LDH and CRP in Cervical Cancer. Onco Targets Ther 2020;13:1255-63. [PMID: 32103993 DOI: 10.2147/OTT.S235027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Worthley DL, Bardy PG, Gordon DL, Mullighan CG. Mannose-binding lectin and maladies of the bowel and liver. World J Gastroenterol 2006; 12(40): 6420-6428 [PMID: 17072973 DOI: 10.3748/wjg.v12.i40.6420] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
67 Cole DS, Watts A, Scott-Coombes D, Avades T. Clinical utility of peri-operative C-reactive protein testing in general surgery. Ann R Coll Surg Engl 2008;90:317-21. [PMID: 18492397 DOI: 10.1308/003588408X285865] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
68 Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen PL, Joensuu H, Hermunen K, Soveri LM, Boisen MK, Dehlendorff C, Johansen JS, Haglund C, Osterlund P. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers (Basel) 2021;13:3892. [PMID: 34359796 DOI: 10.3390/cancers13153892] [Reference Citation Analysis]
69 Zhao X, Luo J, Li B, Liu S, Li D. The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection--a retrospective study. PLoS One. 2015;10:e0116909. [PMID: 25602444 DOI: 10.1371/journal.pone.0116909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
70 Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep. 2002;4:250-255. [PMID: 11937016 DOI: 10.1007/s11912-002-0023-1] [Cited by in Crossref: 205] [Cited by in F6Publishing: 185] [Article Influence: 10.3] [Reference Citation Analysis]